Elevance Health Stock News

Elevance Health, Inc. (NYSE:ELV ) Q2 2025 Earnings Conference Call July 17, 2025 8:30 AM ET Company Participants Felicia Farr Norwood - Executive VP & President of Government Health Benefits Gail Koziara Boudreaux - President, CEO & Director Mark Bradley Kaye - Executive VP & CFO Morgan Kendrick - Corporate Participant Nathan Allen Rich - Vice President of Investor Relations Peter David Haytaia...

The health insurer now expects 2025 earnings of just $30 a share, citing ongoing and industry-wide impact of elevated cost trends in ACA and Medicaid.

A majority of publicly traded US health insurers are expected to post QoQ declines in revenue and net income in Q2, according to an S&P Global Market Intelligence analysis of sell-side analyst forecasts. Of the eight largest publicly traded US managed care insurers, all but two — UnitedHealth Group and Alignment Healthcare — are projected to report lower revenue compared with Q1 2025, while all...

Elevance lowered its annual profit forecast on Thursday as it expects elevated medical costs in its government-backed plans to persist, sending its shares 7% lower in premarket trading.

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported second quarter 2025 results. "In the second quarter, Elevance Health made meaningful progress in delivering an experience that is simple and personal to those we serve, while advancing our efforts to enhance efficiency across the healthcare system. We are updating our outlook to reflect elevated medical cost trends in ACA...

The market often misinterprets price declines as value. For Elevance Health, I see a disconnect between market cap and long-term earnings potential. Health sector valuations have dropped sharply, but lower multiples reflect uncertainty, not necessarily increased risk for robust companies like ELV. Elevance Health stands out for its ability to manage industry uncertainties and is well-positioned...

Bragar Eagel & Squire, P.C. Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Elevance (ELV) To Contact Him Directly To Discuss Their Options

Elevance Health (NYSE:ELV) is set to report its earnings on Thursday, July 17, 2025. For traders focused on events, analyzing past stock performance surrounding earnings announcements can yield valuable insights and potentially improve trading strategies.